Clinical trial
A Randomized, Participant-Blinded, Sham-Controlled Study of Noninvasive Hypersound Radiofrequency Neuromodulation for Chronic Neuropathic and Radicular Pain
NCT07831447 is registered in ClinicalTrials.gov with Hypersound Medical Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Participant-Blinded, Sham-Controlled Study of Noninvasive Hypersound Radiofrequency Neuromodulation for Chronic Neuropathic and Radicular Pain
- Lead sponsor
- Hypersound Medical Inc
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2027
- Completion date
- June 30, 2028
- Enrollment
- 71 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic neuropathic pain, peripheral neuropathic pain, radiculopathy, sciatica